Q2 STOCKS TO BUY

What Has These 3 Biotechs Popping Right Now?

Five Prime Therapeutics Inc (NASDAQ:FPRX), OXiGENE Inc (NASDAQ:OXGN), and XBiotech Inc (NASDAQ:XBIT) are making big news on their respective fundamental developments

May 27, 2015 at 1:03 PM
facebook X logo linkedin


Biotechs are having a big day, and sector components Five Prime Therapeutics Inc (NASDAQ:FPRX), OXiGENE Inc (NASDAQ:OXGN), and XBiotech Inc (NASDAQ:XBIT) are no exception. All three stocks are soaring in the wake of well-received fundamental developments -- moves that for at least one of the stocks could have short sellers shaking in their boots.

Specifically, FPRX is up 11.6% at $21.92 -- and on track to close north of its 40-day moving average for the first time since April 24 -- on reports of a new partnership with fellow drugmaker bluebird bio Inc (NASDAQ:BLUE). While the stock still remains 18.8% lower on the year, a continued rise could prompt some of the weaker bearish hands to hit the exits. Currently, 8.1% of the stock's float is sold short, and would take more than seven sessions to cover, at Five Prime Therapeutics Inc's average daily pace of trading.

OXGN, meanwhile, has tacked on 6.5% to trade at $1.47, after the company said it was given a patent for its experimental cancer drug, OXi4503. Today's pop is much needed, considering the shares have surrendered 47% of their value over the past 52 weeks, and hit a record low of $1.31 on May 8. Analysts, however, have kept the faith, with each of those covering OXiGENE Inc maintaining a "strong buy" rating. Plus, the average 12-month price target of $6.25 sits in territory not charted since October 2012.

XBIT was up 13.3% at its intraday peak -- and was last seen 1.7% higher at $20.56 -- after the company said it successfully cloned an anti-Ebola product. Since opening for trading at $23 in mid-April, shares of XBiotech Inc have shed 10.6%, and along the way, hit an April 21 all-time peak of $32.50 and a May 1 record low of $17.06. Short sellers haven't shown much interest yet, as less than 1% of the stock's float is sold short.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter